共 7 条
[1]
N-terminal pro–brain natriuretic peptide testing in the emergency department: Beneficial effects on hospitalization, costs, and outcome[J] . Joost H.W. Rutten,Ewout W. Steyerberg,Frans Boomsma,Jan L.C.M. van Saase,Jaap W. Deckers,Henk C. Hoogsteden,Jan Lindemans,Anton H. van den Meiracker.American Heart Journal . 2008 (1)
[2]
Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema[J] . Michael Behnes,Martina Brueckmann,Parviz Ahmad-Nejad,Siegfried Lang,Christian Wolpert,Elif Elmas,Thorsten Kaelsch,Joachim Gruettner,Christel Weiβ,Martin Borggrefe,Michael Neumaier.International Journal of Cardiology . 2008 (2)
[3]
Nesiritide added to standard care favorably reduces systolic blood pressure compared with standard care alone in patients with acute decompensated heart failure[J] . W. Franklin Peacock,Charles L. Emerman,Marc A. Silver.American Journal of Emergency Medicine . 2005 (3)
[4]
B-type natriuretic peptide in cardiovascular disease
[J].
LANCET,
2003, 362 (9380)
:316-322
de Lemos, JA
;
McGuire, DK
;
Drazner, MH
.
[5]
Incidence and epidemiology of heart failure
[J].
Heart Failure Reviews,
2000, 5 (2)
:167-173
Kannel W.B.
.
[6]
Prevalence and misdi-agnosis of chronic heart failure in nursing home residents:the roleof B-type natriuretic peptides. M.Barents,I.C.C.van der Horst Met al. Netherlands Heart Journal . 2008
[7]
Nesiritide in the initial management of acute decompensated congestive heart failure. A Sakr,P Hahn,T Donohue,A Ghantous. Connecticut Medicine . 2008